ALCIDION GROUP LIMITED (ALC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALC - ALCIDION GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -1.4
Index:

Alcidion Group provides clinical information technology to support clinicians in decision making, ensuring quality of care for patients. The company operates in Australia and the UK. It listed on the ASX in 2011.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.074

30 Nov
2023

0.000

OPEN

$0.08

0.000

HIGH

$0.08

1,105,723

LOW

$0.07

TARGET
$0.08 8.1% upside
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . BMT . CAJ . DOC . EBO . HLA . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA .
FNARENA'S MARKET CONSENSUS FORECASTS
ALC: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx - 0.3 - 0.2 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-0.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx40.4 M
Book Value Per Share xxxxxxxxxxxxxxx7.1
Net Operating Cash Flow xxxxxxxxxxxxxxx0.2 M
Net Profit Margin xxxxxxxxxxxxxxx-8.95 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-3.93 %
Return on Invested Capital xxxxxxxxxxxxxxx-3.86 %
Return on Assets xxxxxxxxxxxxxxx-2.90 %
Return on Equity xxxxxxxxxxxxxxx-3.93 %
Return on Total Capital xxxxxxxxxxxxxxx-5.01 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-0.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx68 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx15 M
Price To Book Value xxxxxxxxxxxxxxx1.34

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.5 M
Capex % of Sales xxxxxxxxxxxxxxx1.12 %
Cost of Goods Sold xxxxxxxxxxxxxxx39 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx6 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

03/11/2023

3

Downgrade to Hold from Buy

$0.08

8.11%

Alcidion Group's Sep Q update showed the largest net outflow of net operating capital experienced in the last two years, Bell Potter notes. This has disappointingly led to a capital raise, but only a modest $6m to bloster the balance sheet.

Contracted revenue for FY24 has seen an increase of 12% year on year, however quarterly cash payments also increased 16%.

Considering the nature of the capital raise, persisting delays to contract wins, and increasing cost base, Bell Potter has lowered short-term earnings forecasts and increased its risk discount. Downgrade to Hold from Buy, target falls to 8c from 16c.

FORECAST
Bell Potter forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -0.20 cents.
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.10 cents.
Access Stockbroker Research History >

ALC STOCK CHART

FNArena News on ALC

1
Australian Broker Call *Extra* Edition – Nov 15, 2023

Nov 15 2023 - Daily Market Reports
2
Australian Broker Call *Extra* Edition – Nov 09, 2023

Nov 09 2023 - Daily Market Reports
3
Weekly Ratings, Targets, Forecast Changes – 03-11-23

Nov 06 2023 - Weekly Reports
4
FNArena Corporate Results Monitor – 25-08-2023

Aug 25 2023 - Australia
5
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps

Latest Healthcare services News

1
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
2
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
3
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
4
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
5
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
6
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
7
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps
8
Healius Offers Digital Carrot, Base Remains Soft

May 25 2022 - Australia
9
Ramsay Stakes Future on Mental Health

Dec 20 2021 - Australia
10
Ramsay Health Care: Finally A Break-Out

Nov 09 2021 - Technicals